March 6, 2017
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) on March 3 recommended approval for a batch of drugs including Takeda Pharmaceutical’s multiple myeloma (MM) drug ixazomib, sold as Ninlaro overseas. These drugs are expected to...read more